People · Operator
Named in public records as an officer, director or promoter · active 2021–2025 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Renasant Bio, Inc. | — | Biotechnology | Series B | $55.5M | $143.9M | 2025 |
| Entact Bio, Inc. | — | Biotechnology | Series C | $40.3M | $426.4M | 2024 |
| Cardialen, Inc. | — | Other Health Care | Series B | $28.2M | $71.8M | 2021 |
Anna French at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Anna French on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kevin Bitterman | 1 | 15 |
| Richard Gaster | 1 | 7 |
| Alon Lazarus | 1 | 7 |
| WILLIAM SCHMIDT | 1 | 7 |
| Jay Schmelter | 1 | 6 |
| Andrew Sinclair | 1 | 5 |
| Thomas Thaler | 1 | 4 |
| JEFF PETERS | 1 | 4 |
| Warren Watson | 1 | 3 |
| ROBERT J. CALCATERRA | 1 | 3 |
| Deborah Palestrant | 1 | 3 |
| June Lee | 1 | 3 |
| Natalie Holles | 1 | 2 |
| ERIC A. GULVE | 1 | 2 |
| Evan Caplan | 1 | 2 |
| Emily Conley | 1 | 2 |
| Igor J. Efimov | 1 | 1 |
| Warren A. Watson | 1 | 1 |
| PAULA A. SKJEFTE | 1 | 1 |
| IGOR R. EFIMOV | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.